Form 4: Cardlytics Chief Legal Officer Reports Routine RSU Vesting and Tax-Related Stock Sale

Cardlytics' Chief Legal & Privacy Officer, Nicholas Hollmeyer Lynton, reported the vesting of restricted stock units and a subsequent sale of shares solely to cover tax obligations.

Summary

• Nicholas Hollmeyer Lynton, Chief Legal & Privacy Officer of Cardlytics, Inc. (CDLX), reported transactions on July 1 and July 2, 2025.
• On July 1, 2025, Lynton acquired a total of 12,788 shares of common stock through the vesting and conversion of Restricted Stock Units (RSUs), comprising 10,629 shares, 581 shares, and 1,578 shares from three separate awards.
• Following these acquisitions, Lynton's direct beneficial ownership of common stock increased to 114,907 shares.
• On July 2, 2025, Lynton sold 5,271 shares of common stock at a weighted average price of $1.7826 per share, with individual sales ranging from $1.66 to $1.8451.
• The sale was exclusively to satisfy tax withholding obligations that resulted from the RSU vesting, and no shares were sold for any other purpose.
• After the sale, Lynton's direct beneficial ownership of common stock was 109,636 shares.
• Lynton continues to hold 31,889, 1,744, and 6,312 Restricted Stock Units from the three awards, which are subject to future vesting contingent on continued employment.

Sentiment

Score: 6

Explanation: The document is neutral to slightly positive. It reports a routine insider transaction (RSU vesting and tax sale), which is expected. The fact that the sale was only for tax purposes is a minor positive, as it doesn't indicate a lack of confidence from the insider.

Positives

• The sale of shares was solely for tax withholding purposes, indicating no discretionary selling by the officer.
• The officer continues to hold a significant number of shares and unvested RSUs, aligning their interests with shareholders.

Negatives

• The sale price of $1.7826 per share is relatively low, reflecting the current market valuation of the stock.

Risks

• Continued employment is a condition for future RSU vesting, posing a risk to the officer's future equity compensation if employment ceases.
• The value of the vested shares and future RSU vesting is subject to the volatility of Cardlytics' common stock price.

Future Outlook

The document indicates future vesting of Restricted Stock Units for the reporting person, contingent on continued employment, which will result in additional share acquisitions and potential tax-related sales.

Management Comments

• The Reporting Person did not sell shares for any other purpose than to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on July 1, 2025.

Industry Context

This Form 4 filing is a routine disclosure of insider stock transactions, common across publicly traded companies. It reflects standard equity compensation practices where Restricted Stock Units vest over time, and a portion of the vested shares are often sold to cover statutory tax obligations. Such transactions do not typically signal a change in strategic direction or financial performance, but rather the mechanics of executive compensation.

Comparison to Industry Standards

• The RSU vesting and subsequent tax-related sale are standard practices for executive compensation in the technology and financial services industries. Companies like PayPal, Block, or other fintech firms often use RSUs as a key component of their executive compensation packages, with similar tax withholding sales observed.
• The specific vesting schedules (e.g., quarterly over multiple years) are also common, designed to retain talent and align executive interests with long-term shareholder value.
• The sale price of $1.7826 reflects the current market valuation of Cardlytics, which would need to be compared against peer company stock performance and valuation metrics (e.g., P/S, EV/Sales) to assess relative performance, though this document alone does not provide such comparative financial data.

Stakeholder Impact

• Shareholders: The report provides transparency on insider holdings and compensation mechanics. The sale for tax purposes is a neutral event, not indicating a lack of confidence.
• Employees: The RSU vesting structure highlights the company's equity compensation strategy, which can be a factor in employee retention and motivation.

Next Steps

• Future vesting of remaining Restricted Stock Units on various dates through April 1, 2026, contingent on continued employment.

Key Dates

Recommendation

Keywords

Cardlytics, CDLX, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU, Stock Vesting, Tax Withholding, Beneficial Ownership, Corporate Officer, Equity Compensation